Resource Library

The pandemic triggered an increase in the number and types of requests for reasonable accommodation, particularly in connection with returning to the workplace, vaccinations, face coverings and remote work. Employers should have a process for handling potential exemption requests for any mandatory vaccination requirements and reasonable accommodation requests for disability or sincerely held religious beliefs as well as a process that complies with a dizzying array of dynamic state requirements.

Since the Spring of 2020, employers have faced enormous practical and legal challenges due to the COVID-19 pandemic. On top of navigating the practical realities of the evolving public health emergency and related regulatory guidance, employers have had to affirmatively respond to shifting legal obligations and balance human resources considerations. Employers must continue to monitor the public health and legal landscape, as well as related HR considerations.

While COVID-19 has affected virtually every single employee and employer, caregivers — women in particular — have been disproportionately affected by the pandemic as a result of the increased demands they face as caretakers at home.

A basic outline of an attorney-client privilege and work product doctrine.

The ACC-Smarter Law Solutions free benchmarking and consultation service (acc.com/smarterlaw) has proven to be a hit since its launch in 2019. While we are thrilled at the positive feedback we’ve received from our clients, we thought that it would be interesting to respond directly to a few widely held hesitancies expressed by those considering a basic benchmarking or performance improvement process. We gathered some of these questions and sent them to Smarter Law Solutions CEO, Trevor Faure for his candid counsel. We were particularly interested in his perspective on concerns about taking on a consultant agreement in these turbulent times for legal operations.

Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.

Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.

The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.

Amendments to the Canadian Patent Act and enactment of the Certificate of Supplementary Protection Regulations flowing from the Canada-European Union (EU) Comprehensive Economic and Trade Agreement introduced a new framework in Canada for the issuance of Certificates of Supplementary Protection (CSPs).

This chart compare key aspects of the two regimes, Canada's and the EU's.

Patented medicine regulations in Canada can be complex and the review process is fast-paced. In this Top Ten, in-house counsel will learn the essential points of how to prepare for the "Regulations" review. Editor's note: This article was updated to reflect recent developments; a prior version of this article was published on August 6, 2020.

A handbook regarding multinational business acquisition and integration. Key topics such as tax, corporate law, employment and compliance are considered and regional comparison tables summarize the main tax, employment and corporate aspects of integrations in more than 40 countries.